药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Flurandrenolide
Sodium citrate
Chlorprothixene may increase the neurotoxic activities of Sodium citrate.
Flurandrenolide
Polymyxin B
Chlorprothixene may increase the neurotoxic activities of Polymyxin B.
Flurandrenolide
Valproate bismuth
Chlorprothixene may increase the neurotoxic activities of Valproate bismuth.
Flurandrenolide
Bismuth subgallate
Chlorprothixene may increase the neurotoxic activities of Bismuth subgallate.
Flurandrenolide
Bismuth subnitrate
Chlorprothixene may increase the neurotoxic activities of Bismuth subnitrate.
Flurandrenolide
Pirlimycin
Chlorprothixene may increase the neurotoxic activities of Pirlimycin.
Flurandrenolide
Bismuth subcarbonate
Chlorprothixene may increase the neurotoxic activities of Bismuth subcarbonate.
Flurandrenolide
Bismuth subcitrate potassium
Chlorprothixene may increase the neurotoxic activities of Bismuth subcitrate potassium.
Flurandrenolide
Lincomycin
Chlorprothixene may increase the neurotoxic activities of Lincomycin.
Flurandrenolide
Imipenem
Chlorprothixene may increase the neurotoxic activities of Imipenem.
Flurandrenolide
Bismuth subsalicylate
Chlorprothixene may increase the neurotoxic activities of Bismuth subsalicylate.
Flurandrenolide
Relugolix
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Relugolix.
Flurandrenolide
Fostemsavir
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Fostemsavir.
Flurandrenolide
Acetyldigoxin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Acetyldigoxin.
Flurandrenolide
Talinolol
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Talinolol.
Flurandrenolide
Dabrafenib
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Dabrafenib.
Flurandrenolide
Indacaterol
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Indacaterol.
Flurandrenolide
Celiprolol
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Celiprolol.
Flurandrenolide
Lopinavir
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Lopinavir.
Flurandrenolide
Digitoxin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Digitoxin.